Royal Bank Of Canada Immunity Bio, Inc. Transaction History

Royal Bank Of Canada

$458 Billion
Q1 2025

A detailed history of Royal Bank Of Canada transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 57,073 shares of IBRX stock, worth $165,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,073

Previous 103,757 44.99%

Holding current value

$165,511

Previous $265,000 35.47%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.32 - $3.9 $108,306 - $182,067	-46,684 Reduced 44.99%	57,073 $171,000
Q4 2024 Feb 14, 2025	SELL	$2.56 - $6.17 $60,874 - $146,716	-23,779 Reduced 18.64%	103,757 $265,000
Q3 2024 Nov 14, 2024	SELL	$3.32 - $6.7 $1.14 Million - $2.3 Million	-342,658 Reduced 72.88%	127,536 $473,000
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $2.01 Million - $3.81 Million	416,596 Added 777.26%	470,194 $2.97 Million
Q1 2024 Nov 05, 2024	SELL	$3.23 - $6.17 $1.35 Million - $2.57 Million	-416,596 Reduced 88.6%	53,598 $287,000
Q1 2024 May 15, 2024	SELL	$3.23 - $6.17 $103,133 - $197,008	-31,930 Reduced 37.33%	53,598 $287,000
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $1,261 - $5,256	1,009 Added 1.19%	85,528 $429,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $3.1 $44,544 - $107,046	34,531 Added 69.08%	84,519 $142,000
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $6,964 - $29,178	4,552 Added 10.02%	49,988 $138,000
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $189,155 - $669,749	-140,115 Reduced 75.51%	45,436 $82,000
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.77 $625,721 - $973,823	143,844 Added 344.89%	185,551 $940,000
Q3 2022 Nov 14, 2022	SELL	$3.65 - $6.43 $23,652 - $41,666	-6,480 Reduced 13.45%	41,707 $208,000
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $17,436 - $39,946	-6,506 Reduced 11.9%	48,187 $180,000
Q1 2022 May 16, 2022	SELL	$5.05 - $7.53 $72,179 - $107,626	-14,293 Reduced 20.72%	54,693 $308,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $102,604 - $184,217	18,096 Added 35.56%	68,986 $419,000
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $44,520 - $69,135	4,855 Added 10.55%	50,890 $496,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $617,329 - $1.03 Million	46,035 New	46,035 $658,000

Others Institutions Holding IBRX

# of Institutions

239

Shares Held

79.9M

Call Options Held

1.08M

Put Options Held

2.73M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.16B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Immunity Bio, Inc. Transaction History